Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__175_B5,1 | Lung | Primary cancer | 5,849 | Tumor/Malignant | 59.9% | 0.99 | 0.07 |
| NSCLC_38242124__IMC__175_B5,10 | Lung | Primary cancer | 3,111 | Tumor/Malignant | 59.8% | 0.97 | 0.10 |
| NSCLC_38242124__IMC__175_B5,11 | Lung | Primary cancer | 3,572 | Tumor/Malignant | 74.6% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__175_B5,12 | Lung | Primary cancer | 3,967 | Tumor/Malignant | 75.0% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__175_B5,13 | Lung | Primary cancer | 2,364 | Stromal | 34.8% | 0.93 | 0.26 |
| NSCLC_38242124__IMC__175_B5,14 | Lung | Primary cancer | 3,391 | Tumor/Malignant | 79.4% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__175_B5,15 | Lung | Primary cancer | 2,515 | Tumor/Malignant | 53.1% | 0.93 | 0.23 |
| NSCLC_38242124__IMC__175_B5,16 | Lung | Primary cancer | 2,891 | Tumor/Malignant | 41.0% | 0.75 | 0.57 |
| NSCLC_38242124__IMC__175_B5,17 | Lung | Primary cancer | 3,442 | Tumor/Malignant | 42.2% | 0.86 | 0.44 |
| NSCLC_38242124__IMC__175_B5,2 | Lung | Primary cancer | 3,313 | Other | 50.7% | 0.90 | 0.29 |
| NSCLC_38242124__IMC__175_B5,3 | Lung | Primary cancer | 3,516 | Tumor/Malignant | 82.0% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__175_B5,4 | Lung | Primary cancer | 3,890 | Tumor/Malignant | 68.2% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__175_B5,5 | Lung | Primary cancer | 3,985 | Tumor/Malignant | 40.6% | 0.94 | 0.21 |
| NSCLC_38242124__IMC__175_B5,6 | Lung | Primary cancer | 3,188 | Tumor/Malignant | 57.0% | 0.96 | 0.16 |
| NSCLC_38242124__IMC__175_B5,7 | Lung | Primary cancer | 3,997 | Tumor/Malignant | 54.5% | 0.95 | 0.18 |
| NSCLC_38242124__IMC__175_B5,8 | Lung | Primary cancer | 2,196 | Tumor/Malignant | 33.9% | 0.87 | 0.41 |
| NSCLC_38242124__IMC__175_B5,9 | Lung | Primary cancer | 3,264 | Tumor/Malignant | 75.1% | 0.97 | 0.10 |
| NSCLC_38242124__IMC__175_B6,1 | Lung | Primary cancer | 5,482 | Tumor/Malignant | 32.3% | 0.76 | 0.52 |
| NSCLC_38242124__IMC__175_B6,10 | Lung | Primary cancer | 3,587 | Tumor/Malignant | 58.7% | 0.97 | 0.11 |
| NSCLC_38242124__IMC__175_B6,11 | Lung | Primary cancer | 3,189 | Tumor/Malignant | 79.2% | 0.99 | 0.05 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__175_B5,1 | Lung | Primary cancer | 5,849 | Tumor/Malignant | 66.8% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__175_B5,10 | Lung | Primary cancer | 3,111 | Tumor/Malignant | 58.0% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__175_B5,11 | Lung | Primary cancer | 3,572 | Tumor/Malignant | 75.5% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__175_B5,12 | Lung | Primary cancer | 3,967 | Tumor/Malignant | 61.9% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__175_B5,13 | Lung | Primary cancer | 2,364 | Stromal | 30.5% | 0.71 | 0.62 |
| NSCLC_38242124__IMC__175_B5,14 | Lung | Primary cancer | 3,391 | Tumor/Malignant | 79.3% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__175_B5,15 | Lung | Primary cancer | 2,515 | Tumor/Malignant | 32.6% | 0.99 | 0.07 |
| NSCLC_38242124__IMC__175_B5,16 | Lung | Primary cancer | 2,891 | Tumor/Malignant | 36.3% | 0.75 | 0.57 |
| NSCLC_38242124__IMC__175_B5,17 | Lung | Primary cancer | 3,442 | Tumor/Malignant | 25.9% | 0.92 | 0.30 |
| NSCLC_38242124__IMC__175_B5,2 | Lung | Primary cancer | 3,313 | Other | 43.1% | 0.75 | 0.54 |
| NSCLC_38242124__IMC__175_B5,3 | Lung | Primary cancer | 3,516 | Tumor/Malignant | 61.6% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__175_B5,4 | Lung | Primary cancer | 3,890 | Tumor/Malignant | 60.7% | 1.00 | 0.04 |
| NSCLC_38242124__IMC__175_B5,5 | Lung | Primary cancer | 3,985 | Tumor/Malignant | 40.7% | 0.94 | 0.21 |
| NSCLC_38242124__IMC__175_B5,6 | Lung | Primary cancer | 3,188 | Tumor/Malignant | 49.9% | 0.98 | 0.10 |
| NSCLC_38242124__IMC__175_B5,7 | Lung | Primary cancer | 3,997 | Tumor/Malignant | 46.7% | 0.97 | 0.11 |
| NSCLC_38242124__IMC__175_B5,8 | Lung | Primary cancer | 2,196 | Tumor/Malignant | 27.7% | 0.89 | 0.34 |
| NSCLC_38242124__IMC__175_B5,9 | Lung | Primary cancer | 3,264 | Tumor/Malignant | 64.5% | 1.00 | 0.04 |
| NSCLC_38242124__IMC__175_B6,1 | Lung | Primary cancer | 5,482 | Tumor/Malignant | 36.3% | 0.74 | 0.58 |
| NSCLC_38242124__IMC__175_B6,10 | Lung | Primary cancer | 3,587 | Tumor/Malignant | 55.8% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__175_B6,11 | Lung | Primary cancer | 3,189 | Tumor/Malignant | 74.5% | 1.00 | 0.02 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__175_B5,1 | Lung | Primary cancer | 5,849 | Tumor/Malignant cell | 71.9% | 0.96 | 0.14 |
| NSCLC_38242124__IMC__175_B5,10 | Lung | Primary cancer | 3,111 | Tumor/Malignant cell | 60.8% | 0.97 | 0.11 |
| NSCLC_38242124__IMC__175_B5,11 | Lung | Primary cancer | 3,572 | Tumor/Malignant cell | 82.6% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__175_B5,12 | Lung | Primary cancer | 3,967 | Tumor/Malignant cell | 75.7% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__175_B5,13 | Lung | Primary cancer | 2,364 | Fibroblast | 31.4% | 0.94 | 0.25 |
| NSCLC_38242124__IMC__175_B5,14 | Lung | Primary cancer | 3,391 | Tumor/Malignant cell | 79.2% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__175_B5,15 | Lung | Primary cancer | 2,515 | Tumor/Malignant cell | 52.8% | 0.93 | 0.23 |
| NSCLC_38242124__IMC__175_B5,16 | Lung | Primary cancer | 2,891 | Tumor/Malignant cell | 62.2% | 0.90 | 0.28 |
| NSCLC_38242124__IMC__175_B5,17 | Lung | Primary cancer | 3,442 | Tumor/Malignant cell | 40.9% | 0.86 | 0.47 |
| NSCLC_38242124__IMC__175_B5,2 | Lung | Primary cancer | 3,313 | Other | 54.6% | 0.88 | 0.32 |
| NSCLC_38242124__IMC__175_B5,3 | Lung | Primary cancer | 3,516 | Tumor/Malignant cell | 81.9% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__175_B5,4 | Lung | Primary cancer | 3,890 | Tumor/Malignant cell | 67.9% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__175_B5,5 | Lung | Primary cancer | 3,985 | Tumor/Malignant cell | 46.1% | 0.92 | 0.28 |
| NSCLC_38242124__IMC__175_B5,6 | Lung | Primary cancer | 3,188 | Tumor/Malignant cell | 56.7% | 0.96 | 0.16 |
| NSCLC_38242124__IMC__175_B5,7 | Lung | Primary cancer | 3,997 | Tumor/Malignant cell | 54.3% | 0.95 | 0.18 |
| NSCLC_38242124__IMC__175_B5,8 | Lung | Primary cancer | 2,196 | Tumor/Malignant cell | 33.3% | 0.87 | 0.41 |
| NSCLC_38242124__IMC__175_B5,9 | Lung | Primary cancer | 3,264 | Tumor/Malignant cell | 78.6% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__175_B6,1 | Lung | Primary cancer | 5,482 | Tumor/Malignant cell | 45.0% | 0.69 | 0.62 |
| NSCLC_38242124__IMC__175_B6,10 | Lung | Primary cancer | 3,587 | Tumor/Malignant cell | 57.5% | 0.97 | 0.10 |
| NSCLC_38242124__IMC__175_B6,11 | Lung | Primary cancer | 3,189 | Tumor/Malignant cell | 79.1% | 0.99 | 0.05 |